ISREC - Administration

Institute

The Swiss Institute for Experimental Cancer Research (ISREC) at EPFL's School of Life Sciences focuses on investigating biological systems involved in cancer development, cell homeostasis, and organ development. Research includes genetically engineered mouse models of human cancer, studying resistance mechanisms to cancer therapy, and exploring signalling pathways regulating embryogenesis and organogenesis. ISREC aims to deepen the understanding of cancer biology and genetics, develop new therapeutic strategies, and contribute to the School of Life Sciences' intellectual community. Directed by Elisa Oricchio, ISREC collaborates with EPFL's Institute of Bioengineering and the Swiss Cancer Center Leman, fostering interdisciplinary research and training students at all career levels.

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

ISREC - Administration

Chat with Graph Search

Exploration and modulation of mechanical cues for enhanced cancer immunotherapy

A Cluster of Evolutionarily Recent KRAB Zinc Finger Proteins Protects Cancer Cells from Replicative Stress–Induced Inflammation

Cytokine-armed dendritic cell progenitors for antigen-agnostic cancer immunotherapy